Aviscumine Terminated Phase 2 Trials for Metastatic Colorectal Cancer (CRC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00932724
CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer